120 related articles for article (PubMed ID: 38634292)
1. Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT).
Garg R; D'Agostino RB; O'Connell N; Lesser GJ; Salloum FN; Hines AL; Meléndez GC; Jordan JH; Ky B; Wagner LI; Sutton AL; Bottinor W; Olson KC; Ladd AC; Hundley WG;
Hypertension; 2024 Jun; 81(6):1365-1373. PubMed ID: 38634292
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
Dang C; Guo H; Najita J; Yardley D; Marcom K; Albain K; Rugo H; Miller K; Ellis M; Shapira I; Wolff AC; Carey LA; Moy B; Groarke J; Moslehi J; Krop I; Burstein HJ; Hudis C; Winer EP; Tolaney SM
JAMA Oncol; 2016 Jan; 2(1):29-36. PubMed ID: 26539793
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.
Meléndez GC; Sukpraphrute B; D'Agostino RB; Jordan JH; Klepin HD; Ellis L; Lamar Z; Vasu S; Lesser G; Burke GL; Weaver KE; Ntim WO; Hundley WG
Am J Cardiol; 2017 May; 119(10):1637-1642. PubMed ID: 28341361
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2-Year Postchemotherapy Measures of Left Ventricular Ejection Fraction.
Suerken CK; D'Agostino RB; Jordan JH; Meléndez GC; Vasu S; Lamar ZS; Hundley WG
J Am Heart Assoc; 2020 Jan; 9(2):e015400. PubMed ID: 31959033
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
[TBL] [Abstract][Full Text] [Related]
6. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function.
Chotenimitkhun R; D'Agostino R; Lawrence JA; Hamilton CA; Jordan JH; Vasu S; Lash TL; Yeboah J; Herrington DM; Hundley WG
Can J Cardiol; 2015 Mar; 31(3):302-7. PubMed ID: 25662284
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol.
Heck SL; Mecinaj A; Ree AH; Hoffmann P; Schulz-Menger J; Fagerland MW; Gravdehaug B; Røsjø H; Steine K; Geisler J; Gulati G; Omland T
Circulation; 2021 Jun; 143(25):2431-2440. PubMed ID: 33993702
[TBL] [Abstract][Full Text] [Related]
8. Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
Morris PG; Dickler M; McArthur HL; Traina T; Sugarman S; Lin N; Moy B; Come S; Godfrey L; Nulsen B; Chen C; Steingart R; Rugo H; Norton L; Winer E; Hudis CA; Dang CT
J Clin Oncol; 2009 Dec; 27(36):6117-23. PubMed ID: 19901120
[TBL] [Abstract][Full Text] [Related]
9. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
[TBL] [Abstract][Full Text] [Related]
10. Changes in Physical Activity, Functional Capacity, and Cardiac Function during Breast Cancer Therapy.
Bellissimo MP; Canada JM; Jordan JH; Ladd AC; Heiston EM; Brubaker P; Mihalko SL; Reding K; D Agostino R; O Connell N; Hackney MH; Weaver KE; Lesser GJ; Avis NE; Hundley WG
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1509. PubMed ID: 35775211
[TBL] [Abstract][Full Text] [Related]
11. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy.
Jolly MP; Jordan JH; Meléndez GC; McNeal GR; D'Agostino RB; Hundley WG
J Cardiovasc Magn Reson; 2017 Aug; 19(1):59. PubMed ID: 28768517
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Mass Change After Anthracycline Chemotherapy.
Jordan JH; Castellino SM; Meléndez GC; Klepin HD; Ellis LR; Lamar Z; Vasu S; Kitzman DW; Ntim WO; Brubaker PH; Reichek N; D'Agostino RB; Hundley WG
Circ Heart Fail; 2018 Jul; 11(7):e004560. PubMed ID: 29991488
[TBL] [Abstract][Full Text] [Related]
13. The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer.
Mabudian L; Reding K; D'Agostino RB; Heiston EM; Bellissimo MP; Olson K; Ntim WO; Klepin HD; Dressler EV; Moore T; Jordan JH; O'Connell NS; Ladd A; Weaver KE; Ky B; Wagner LI; Hackney MH; Lesser GJ; Hundley WG;
Cardiooncology; 2024 Jun; 10(1):34. PubMed ID: 38845066
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
Yoon GJ; Telli ML; Kao DP; Matsuda KY; Carlson RW; Witteles RM
J Am Coll Cardiol; 2010 Nov; 56(20):1644-50. PubMed ID: 21050974
[TBL] [Abstract][Full Text] [Related]
15. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
Geisberg CA; Abdallah WM; da Silva M; Silverstein C; Smith HM; Abramson V; Mayer I; Means-Powell J; Freehardt D; White B; Lenihan D; Sawyer DB
J Card Fail; 2013 Jan; 19(1):10-5. PubMed ID: 23273589
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction.
Nowsheen S; Aziz K; Park JY; Lerman A; Villarraga HR; Ruddy KJ; Herrmann J
J Am Heart Assoc; 2018 Aug; 7(15):e008637. PubMed ID: 30371238
[TBL] [Abstract][Full Text] [Related]
17. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.
Perez EA; Suman VJ; Davidson NE; Kaufman PA; Martino S; Dakhil SR; Ingle JN; Rodeheffer RJ; Gersh BJ; Jaffe AS
J Clin Oncol; 2004 Sep; 22(18):3700-4. PubMed ID: 15365066
[TBL] [Abstract][Full Text] [Related]
18. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
[TBL] [Abstract][Full Text] [Related]
19. Effect at One Year of Adjuvant Trastuzumab for HER2+ Breast Cancer Combined with Radiation or an Anthracycline on Left Ventricular Ejection Fraction.
Andersen MM; Ayala-Peacock D; Bowers J; Kooken BW; D'Agostino RB; Jordan JH; Vasu S; Thomas A; Klepin HD; Brown DR; Hundley WG
Am J Cardiol; 2020 Jun; 125(12):1906-1912. PubMed ID: 32331711
[TBL] [Abstract][Full Text] [Related]
20. Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up.
Narayan HK; Finkelman B; French B; Plappert T; Hyman D; Smith AM; Margulies KB; Ky B
Circulation; 2017 Apr; 135(15):1397-1412. PubMed ID: 28104715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]